Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Interest Coverage Ratio (2018 - 2025)

Historic Interest Coverage Ratio for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to 12.19.

  • X4 Pharmaceuticals' Interest Coverage Ratio rose 1471.72% to 12.19 in Q3 2025 from the same period last year, while for Sep 2025 it was 11.0, marking a year-over-year decrease of 25471.32%. This contributed to the annual value of 4.15 for FY2024, which is 7769.42% up from last year.
  • Per X4 Pharmaceuticals' latest filing, its Interest Coverage Ratio stood at 12.19 for Q3 2025, which was up 1471.72% from 11.75 recorded in Q2 2025.
  • X4 Pharmaceuticals' Interest Coverage Ratio's 5-year high stood at 32.68 during Q2 2024, with a 5-year trough of 31.41 in Q4 2021.
  • Over the past 5 years, X4 Pharmaceuticals' median Interest Coverage Ratio value was 19.9 (recorded in 2024), while the average stood at 16.07.
  • Per our database at Business Quant, X4 Pharmaceuticals' Interest Coverage Ratio skyrocketed by 24536.74% in 2024 and then tumbled by 13596.73% in 2025.
  • Over the past 5 years, X4 Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 31.41 in 2021, then grew by 28.82% to 22.36 in 2022, then soared by 40.24% to 13.36 in 2023, then fell by 16.02% to 15.5 in 2024, then increased by 21.37% to 12.19 in 2025.
  • Its Interest Coverage Ratio was 12.19 in Q3 2025, compared to 11.75 in Q2 2025 and 4.29 in Q1 2025.